An Analysis of Factors Associated with Teacher Turnover in American Overseas Schools von Mancuso, Steven Victor

Volltext

Long-term outcomes with emicizumab prophylaxis for hemophilia A with or without FVIII inhibitors from the HAVEN 1-4 studies von Callaghan, Michael U., Negrier, Claude, Paz-Priel, Ido, Chang, Tiffany, Chebon, Sammy, Lehle, Michaela, Mahlangu, Johnny, Young, Guy, Kruse-Jarres, Rebecca, Mancuso, Maria Elisa, Niggli, Markus, Howard, Monet, Bienz, Nives Selak, Shima, Midori, Jiménez-Yuste, Victor, Schmitt, Christophe, Asikanius, Elina, Levy, Gallia G., Pipe, Steven W., Oldenburg, Johannes

Volltext

A 2-Year Randomized Controlled Trial of Human Caloric Restriction: Feasibility and Effects on Predictors of Health Span and Longevity von Ravussin, Eric, Redman, Leanne M, Rochon, James, Das, Sai Krupa, Fontana, Luigi, Kraus, William E, Romashkan, Sergei, Williamson, Donald A, Meydani, Simin N, Villareal, Dennis T, Smith, Steven R, Stein, Richard I, Scott, Tammy M, Stewart, Tiffany M, Saltzman, Edward, Klein, Samuel, Bhapkar, Manju, Martin, Corby K, Gilhooly, Cheryl H, Holloszy, John O, Hadley, Evan C, Roberts, Susan B

Volltext

Pharmacodynamic Biomarkers in Infants with Hemophilia A Receiving Emicizumab in HAVEN 7 von Kiialainen, Anna, Pipe, Steven, Fijnvandraat, Karin, Kenet, Gili, Schmitt, Christophe, Buri, Muriel, Jiménez-Yuste, Víctor, Oldenburg, Johannes, Mancuso, Maria Elisa, Dhalluin, Christophe, Lehle, Michaela, Collins, Peter

Volltext

Emicizumab Prophylaxis in Infants with Severe Hemophilia A without Factor VIII Inhibitors: Results from the Primary Analysis of the HAVEN 7 Study von Pipe, Steven, Collins, Peter, Dhalluin, Christophe, Kenet, Gili, Schmitt, Christophe, Buri, Muriel, Jiménez-Yuste, Víctor, Peyvandi, Flora, Young, Guy, Oldenburg, Johannes, Mancuso, Maria Elisa, Kavakli, Kaan, Kiialainen, Anna, Chang, Tiffany, Lehle, Michaela, Niggli, Markus, Fijnvandraat, Karin

Volltext

Safety and Efficacy of Emicizumab in Persons with Hemophilia a with or without FVIII Inhibitors: Pooled Data from Four Phase III Studies (HAVEN 1-4) von Callaghan, Michael U., Négrier, Claude, Paz-Priel, Ido, Chang, Tiffany, Chebon, Sammy, Lehle, Michaela, Mahlangu, Johnny, Young, Guy, Kruse-Jarres, Rebecca, Mancuso, Maria Elisa, Niggli, Markus, Kuebler, Peter, Selak Bienz, Nives, Shima, Midori, Jimenez-Yuste, Victor, Schmitt, Christophe, Asikanius, Elina, Levy, Gallia, Pipe, Steven W., Oldenburg, Johannes

Volltext

Design and conduct of the CALERIE study: comprehensive assessment of the long-term effects of reducing intake of energy von Rochon, James, Bales, Connie W, Ravussin, Eric, Redman, Leanne M, Holloszy, John O, Racette, Susan B, Roberts, Susan B, Das, Sai Krupa, Romashkan, Sergei, Galan, Katherine M, Hadley, Evan C, Kraus, William E

Volltext

Emicizumab Prophylaxis for the Treatment of Infants with Severe Hemophilia A without Factor VIII Inhibitors: Results from the Interim Analysis of the HAVEN 7 Study von Pipe, Steven W., Collins, Peter, Dhalluin, Christophe, Kenet, Gili, Schmitt, Christophe, Buri, Muriel, Jiménez-Yuste, Víctor, Peyvandi, Flora, Young, Guy, Oldenburg, Johannes, Mancuso, Maria Elisa, Kiialainen, Anna, Chang, Tiffany, Lehle, Michaela, Fijnvandraat, Karin

Volltext

Low Rebleed Incidence with Eptacog Beta Treatment through 24 and 48 Hours in Children (<12 years) with Hemophilia a or B with Inhibitors von Pipe, Steven, Oldenburg, Johannes, Carcao, Manuel, Chitlur, Meera, Dargaud, Yesim, Davis, Joanna, Escuriola, Carmen, Hay, Charles, Hermans, Cédric, Hwang, Nina, Jiménez-Yuste, Víctor, Kessler, Craig, Mahlangu, Johnny, Mancuso, Maria Elisa, McGuinn, Catherine, Miesbach, Wolfgang, Chrisentery-Singleton, Tammuella, Thornburg, Courtney, Wang, Michael, Bonzo, Daniel, Mitchell, Ian, Wilkinson, Thomas, Dunn, Amy

Volltext